![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|12|6|691-697
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.12, Iss.6, 2006-02, pp. : 691-697
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Caricasole A. Copani A. Caruso A. Caraci F. Iacovelli L. Sortino M.A. Terstappen G.C. Nicoletti F.
Trends in Pharmacological Sciences, Vol. 24, Iss. 5, 2003-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gelsolin as therapeutic target in Alzheimer's disease
By Carro Eva
Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Astroglial Connexins as a Therapeutic Target for Alzheimer's Disease
Current Pharmaceutical Design, Vol. 23, Iss. 33, 2018-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Role of Serotonin in Alzheimer's Disease: A New Therapeutic Target?
CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. :